Francesca Carlomagno
-
- Thyroid Cancer Diagnosis and Treatment 28
- Oncology top 1%
- Cancer-related Molecular Pathways 28
- HER2/EGFR in Cancer Research 13
- Cancer Research top 2%
- Molecular Biology top 2%
- Wnt/β-catenin signaling in development and cancer 9
- DNA Repair Mechanisms 7
-
- Lung Cancer Treatments and Mutations 9
-
- Neuroblastoma Research and Treatments 7
-
- Iron Metabolism and Disorders 7
- Co-authors
- Massimo SantoroAlfredo FuscoGiancarlo VecchioRosa Marina MelilloTeresa GuidaGiuliana SalvatoreSuresh AnagantiMichèle Grieco
- Journals
- Science (1 paper)Journal of Biological Chemistry (2 papers)Angewandte Chemie International Edition (1 paper)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Francesca Carlomagno
88 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Endocrinology, Diabetes and Metabolism 2.5k
- Oncology 2.4k
- Cancer Research 688
- Pathology and Forensic Medicine 776
- Molecular Biology 2.9k
Countries citing papers authored by Francesca Carlomagno
This map shows the geographic impact of Francesca Carlomagno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Carlomagno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Carlomagno more than expected).
Fields of papers citing papers by Francesca Carlomagno
This network shows the impact of papers produced by Francesca Carlomagno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Carlomagno. The network helps show where Francesca Carlomagno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francesca Carlomagno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2017 | 1 | |
| 3 | 2014 | 4 | |
| 4 | 2013 | 21 | |
| 5 | 2013 | 91 | |
| 6 | 2013 | 11 | |
| 7 | 2012 | 17 | |
| 8 | 2010 | 17 | |
| 9 | 2009 | 53 | |
| 10 | 2005 | 14 | |
| 11 | 2004 | 106 | |
| 12 | 2004 | 136 | |
| 13 | 2004 | 69 | |
| 14 | 2002 | 126 | |
| 15 | 2001 | 54 | |
| 16 | 2000 | 143 | |
| 17 | 1999 | 33 | |
| 18 | 1998 | 51 | |
| 19 | 1993 | 60 | |
| 20 | 1992 | 307 |
About Francesca Carlomagno
Francesca Carlomagno is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Hematology, having authored 92 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (28 papers), Thyroid Cancer Diagnosis and Treatment (28 papers), HER2/EGFR in Cancer Research (13 papers), Lung Cancer Treatments and Mutations (9 papers), Wnt/β-catenin signaling in development and cancer (9 papers), DNA Repair Mechanisms (7 papers), Neuroblastoma Research and Treatments (7 papers) and Iron Metabolism and Disorders (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.5k citations), Oncology (2.4k citations) and Cancer Research (688 citations). Francesca Carlomagno has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Massimo Santoro, Alfredo Fusco, Massimo Santoro, Giancarlo Vecchio, Rosa Marina Melillo, Teresa Guida, Giuliana Salvatore, Suresh Anaganti, Michèle Grieco and Anderson J. Ryan. Their work appears in journals such as Science, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.